Can B Corp. engages in the business of promoting health and wellness through developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass, and the licensing of durable medical devices. The company is headquartered in Hicksville, New York and currently employs 12 full-time employees. The company went IPO on 2011-03-11. The firm is engaged in developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. Its products include oils, creams, moisturizers, isolates, gel caps, spa products, and concentrates and lifestyle products. The company develops its own line of proprietary products, as well as seeks synergistic value through acquisitions in the hemp industry. Its Duramed Division provides a sam Pro 2.0 medical device to patients through a doctor program whereby the physician evaluates the patients' needs for medical necessity, and if determined that the device use would be beneficial, writes a prescription for the patient, who signs a rental form, for a 35-day cycle for the unit, that is submitted to Duramed who bills the appropriate insurance company. The firm is also focuses on protecting and commercializing the cannabis patents covering liquid formulations of cannabis.
Follow-Up Questions
Can B Corp 'in CEO'su kimdir?
Mr. Marco Alfonsi 2018 'den beri şirketle birlikte olan Can B Corp 'in Chairman of the Board 'ıdır.
CANB hissesinin fiyat performansı nasıl?
CANB 'in mevcut fiyatı $0.025 'dir, son işlem günde 0% decreased etti.
Can B Corp için ana iş temaları veya sektörler nelerdir?
Can B Corp Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Can B Corp 'in piyasa değerlemesi nedir?
Can B Corp 'in mevcut piyasa değerlemesi $1.9M 'dir
Can B Corp al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 3 analist Can B Corp için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 4 al, 1 tut, 0 sat ve 2 güçlü sat içermektedir